These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23630299)

  • 1. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
    Karimian N; Qin T; Liang T; Osundiji M; Huang Y; Teich T; Riddell MC; Cattral MS; Coy DH; Vranic M; Gaisano HY
    Diabetes; 2013 Aug; 62(8):2968-77. PubMed ID: 23630299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.
    Yue JT; Burdett E; Coy DH; Giacca A; Efendic S; Vranic M
    Diabetes; 2012 Jan; 61(1):197-207. PubMed ID: 22106159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.
    Yue JT; Riddell MC; Burdett E; Coy DH; Efendic S; Vranic M
    Diabetes; 2013 Jul; 62(7):2215-22. PubMed ID: 23434929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats.
    Hoffman EG; Jahangiriesmaili M; Mandel ER; Greenberg C; Aiken J; D'Souza NC; Pasieka A; Teich T; Chan O; Liggins R; Riddell MC
    Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34477204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes.
    Hoffman EG; D'Souza NC; Aiken J; Atherley S; Liggins R; Riddell MC
    Diabetes Obes Metab; 2023 Jun; 25(6):1547-1556. PubMed ID: 36734462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
    de Heer J; Rasmussen C; Coy DH; Holst JJ
    Diabetologia; 2008 Dec; 51(12):2263-70. PubMed ID: 18795252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats.
    Cejvan K; Coy DH; Efendic S
    Diabetes; 2003 May; 52(5):1176-81. PubMed ID: 12716749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K
    Singh B; Khattab F; Chae H; Desmet L; Herrera PL; Gilon P
    Mol Metab; 2021 Nov; 53():101268. PubMed ID: 34118477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.
    Vergari E; Knudsen JG; Ramracheya R; Salehi A; Zhang Q; Adam J; Asterholm IW; Benrick A; Briant LJB; Chibalina MV; Gribble FM; Hamilton A; Hastoy B; Reimann F; Rorsman NJG; Spiliotis II; Tarasov A; Wu Y; Ashcroft FM; Rorsman P
    Nat Commun; 2019 Jan; 10(1):139. PubMed ID: 30635569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
    Gilor C; Duesberg C; Elliott DA; Feldman EC; Mundinger TO; Taborsky GJ; Nelson RW; Havel PJ
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1074-E1083. PubMed ID: 33044845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic polypeptide and other pancreatic hormones in spontaneously diabetic BB/W rats.
    Tomita T; Doull V; Fredrickson D; Pollock G
    Pancreas; 1990 Nov; 5(6):658-67. PubMed ID: 1980735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.
    Leclair E; Liggins RT; Peckett AJ; Teich T; Coy DH; Vranic M; Riddell MC
    Diabetologia; 2016 Aug; 59(8):1724-31. PubMed ID: 27075449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells.
    Vieira E; Salehi A; Gylfe E
    Diabetologia; 2007 Feb; 50(2):370-9. PubMed ID: 17136393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The somatostatin receptor in human pancreatic β-cells.
    Braun M
    Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.
    Diem P; Redmon JB; Abid M; Moran A; Sutherland DE; Halter JB; Robertson RP
    J Clin Invest; 1990 Dec; 86(6):2008-13. PubMed ID: 2254456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.